BiopharmaTrend.com highlighted 11 entrepreneurial women, leading the way in applying advanced computational technologies, such as machine learning, deep learning, and other artificial intelligence components, for tackling some of the hardest challenges of science—in drug discovery and health care. Among those recognized is MassNextGen Entrepreneur Liz O’Day. The Massachusetts Next Generation Initiative (MassNextGen) aims to ensure greater gender parity in the next generation of life science entrepreneurs. Through a competitive program, women-led early-stage life science companies are awarded a year-long customized package of support, which includes non-dilutive grant funding and access to a network of seasoned Executive Coaches from the life sciences ecosystem to refine their business strategies and effectively raise capital.
